Results 291 to 300 of about 106,112 (301)

Tocilizumab

Reactions Weekly, 2019
openaire   +2 more sources

Effect of interleukin-6 receptor inhibition with tocilizumab in patients with rheumatoid arthritis (OPTION study): a double-blind, placebo-controlled, randomised trial

Lancet, The, 2008
Josef S Smolen, Andrea Rubbert-Roth, César R Ramos-Remus   +2 more
exaly  

Single-cell analysis of two severe COVID-19 patients reveals a monocyte-associated and tocilizumab-responding cytokine storm

Nature Communications, 2020
Chuang Guo, Pengfei Cai, Qiaoni Yu
exaly  

Tocilizumab for induction and maintenance of remission in giant cell arteritis: a phase 2, randomised, double-blind, placebo-controlled trial

Lancet, The, 2016
Peter M Villiger, Stefan Kuchen, Lukas Bütikofer   +2 more
exaly  

Efficacy of Tocilizumab in Patients Hospitalized with Covid-19

New England Journal of Medicine, 2020
John H Stone, Matthew J Frigault, Andrea S Foulkes   +2 more
exaly  

Tocilizumab

Reactions Weekly, 2012
openaire   +2 more sources

Efficacy and safety of tocilizumab in patients with systemic-onset juvenile idiopathic arthritis: a randomised, double-blind, placebo-controlled, withdrawal phase III trial

Lancet, The, 2008
Masaaki Mori, Takako Miyamae, Tadamitsu Kishimoto   +2 more
exaly  

Early rheumatoid arthritis treated with tocilizumab, methotrexate, or their combination (U-Act-Early): a multicentre, randomised, double-blind, double-dummy, strategy trial

Lancet, The, 2016
Thasia G Woodworth, Corrado A Bernasconi, Reinhard Bos   +2 more
exaly  

FDA Approval Summary: Tocilizumab for Treatment of Chimeric Antigen Receptor T Cell-Induced Severe or Life-Threatening Cytokine Release Syndrome

Oncologist, 2018
exaly  

Tocilizumab: A Review in Rheumatoid Arthritis

Drugs, 2017
exaly